glp-1 for diabetes and weight loss Therapy Part 1: Setting Realistic Expectations – Sarah Hormachea GLP-1-based therapies for diabetes, obesity

She was very thorough in explaining what I cou

The brain has high energy demand and sirtuins in neurons (especially SIRT1, SIRT3) regulate neuroprotection, plasticity, and cognition

Neovascularization formed at 16 weeks, and there were acellular capillaries and pericyte ghosts after 6 months ( Immunohistochemistry Staining Tissue sections were deparaffinized with xylene and rehydrated with ethanol, followed by antigen retrieval

Listen to the podcast here: PART 1: PART 2: Part 1 My Personal Perspective I think we all need to start reconsidering how we think about this medication that is having profound results

Since a common side effect of taking a GLP-1 is tiredness, reducing caffeine intake seemed like a proactive way to avoid compounding fatigue and to support better overall energy levels